1Ferri CP,Prince M, Brayne C, etal. Global prevalence ofdementia: a Delphi consensus studyCJ]. Lancet,2005,366(9503):2112-2117.
2Reitz C, Brayne C,Mayeux R. Epidemiology of Alzheimerdisease[J]. Nat Rev Neurol, 2011, 7(3) ; 137-152.
3Profenno LA, Porsteinsson AP, Faraone SV. Meta-analysisof Alzheimer's disease risk with obesity, diabetes, and relateddisorders[J]. Biol Psychiatry,2010,67(6) :505-512.
4Mosconi L,Tsui WH, Rusinek H,et al. Quantitation, re-gional vulnerability, and kinetic modeling of brain glucosemetabolism in mild Alzheimer's disease[J]. Eur J Nucl MedMol Imaging,2007,34 (9); 1467-1479.
5Hoyer S. Brain glucose and energy metabolism abnormalitiesin sporadic Alzheimer disease. Causes and consequences: anupdate[J]. Exp. Gerontol,2000,35 (9-10) : 1363-1372.
6Liu Y,Liu F, Iqbal K,et al. Decreased glucose transporterscorrelate to abnormal hyperphosphorylation of tau in Alzhei-mer disease[J]. FEBS Lett, 2008,582(2):359-364.
7Lefebvre T, Ferreira S, Dupont-Wallois L,et al. Evidence abalance between phosphorylation and O-GlcNAc glycosyla-tion of Tau proteins a role in nuclear localization[J]. BiochimBiophys Acta, 2003,1619(2):167- 176.
8Liu Y,porters* O-GlcNAcylation ?betes and Alzheimer^ disease[J]. J Neurochem, 2009,111(1):242-249.
9Deng Y, Li B,Liu Y,et al. Dysregulation of insulin signa-ling, glucose transporters, O-GlcNAcylation,and phospho-rylation of tau and neurofilaments in the brain: Implicationfor Alzheimer^s disease [J]. Am J Pathol, 2009, 175 (5):2089-2098.
10Steen E, Terry BM, Rivera EJ,et al. Impaired insulin andinsulin-like growth factor expression and signaling mecha-nisms in Alzheimer、disease is this type 3 diabetes? [J]. JAlzheimers Dis, 2005,7 (1):63-80.
